News from lexicon pharmaceuticals, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Nov 21, 2014, 01:00 ET

Lexicon Announces Pricing Of Convertible Senior Notes Offering

 Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that it has priced its offering of $80,000,000 aggregate principal amount of...

Nov 21, 2014, 01:00 ET

Lexicon Announces Pricing Of Common Stock Offering

 Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced the pricing of its previously announced underwritten public offering of...

Nov 19, 2014, 16:01 ET

Lexicon Announces Proposed Convertible Senior Notes Offering

 Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that it commenced an offering to sell, subject to market and other conditions,...

Nov 19, 2014, 16:01 ET

Lexicon Announces Proposed Common Stock Offering

 Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that it commenced an offering to sell, subject to market and other conditions,...

Nov 04, 2014, 16:15 ET

Lexicon Strengthens Clincial Operations And Commercial Readiness

 Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) announced today management additions directed towards the completion of Phase 3 development and...

Nov 04, 2014, 16:05 ET

Lexicon Pharmaceuticals Provides Clinical Pipeline Update And Reports 2014 Third Quarter Financial Results

 Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a biopharmaceutical company focused on developing breakthrough treatments for human disease,...

Nov 03, 2014, 07:00 ET

Lexicon To Report Third Quarter 2014 Financial Results On November 4, 2014

Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a biopharmaceutical company focused on developing breakthrough treatments for human disease, will...

Oct 22, 2014, 01:01 ET

Lexicon and Ipsen enter into ex-North America/Japan licensing and commercialization agreement for telotristat etiprate

 Ipsen (Euronext: IPN; ADR: IPSEY) and Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that they have entered into an exclusive...

Sep 11, 2014, 16:30 ET

Lexicon Announces A Publication In The American Diabetes Association's Journal, Diabetes Care

 Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), announced a publication in the online edition of the American Diabetes Association's journal,...

Sep 04, 2014, 07:00 ET

Lexicon To Present At The Morgan Stanley 2014 Global Healthcare Conference

 Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) announced today that Lexicon management will present at the Morgan Stanley 2014 Global Healthcare...

Aug 08, 2014, 08:00 ET

Lexicon To Present At The 2014 Wedbush Life Sciences Management Access Conference

 Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) announced today that Lexicon management will present at the 2014 Wedbush Life Sciences Management...

Aug 07, 2014, 07:00 ET

Lexicon Pharmaceuticals Provides Clinical Pipeline Update And Reports 2014 Second Quarter Financial Results

 Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a biopharmaceutical company focused on developing breakthrough treatments for human disease,...

Aug 05, 2014, 07:00 ET

Lexicon To Report Second Quarter 2014 Financial Results On August 7, 2014

Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a biopharmaceutical company focused on developing breakthrough treatments for human disease, will...

Jul 09, 2014, 07:00 ET

Lexicon And JDRF Collaborate For Phase 2 Clinical Trial Of LX4211 In Type 1 Diabetes

 Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) announced today that JDRF, the world's largest non-profit supporter of type 1 diabetes (T1D)...

Jul 07, 2014, 16:15 ET

Lexicon Announces Appointment of Lonnel Coats as President and Chief Executive Officer

 Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) announced today that Lonnel Coats has been appointed president and chief executive officer...

Jun 14, 2014, 13:15 ET

Lexicon Presents LX4211 Data at American Diabetes Association Meeting

Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), presented data at the 74th Scientific Sessions of the American Diabetes Association (ADA) in San...

May 30, 2014, 17:00 ET

Lexicon To Present At The Jefferies 2014 Global Healthcare Conference

 Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) announced today that Lexicon management will present at the Jefferies 2014 Global Healthcare...

May 09, 2014, 07:00 ET

Lexicon To Present At The 2014 Bank of America Merrill Lynch Healthcare Conference

 Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) announced today that Lexicon management will present at the 2014 Bank of America Merrill Lynch...

May 08, 2014, 06:00 ET

Lexicon Pharmaceuticals Provides Clinical Pipeline Update And Reports 2014 First Quarter Financial Results

Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a biopharmaceutical company focused on developing breakthrough treatments for human disease, today...

May 05, 2014, 07:00 ET

Lexicon To Report First Quarter 2014 Financial Results On May 8, 2014

Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a biopharmaceutical company focused on developing breakthrough treatments for human disease, will...